(redirected from gouty arthritis)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to gouty arthritis: rheumatoid arthritis

GOUT, med. jur. contracts. An inflammation of the fibrous and ligamentous parts of the joints.
     2. In cases of insurance on lives, when there is warranty of health, it seems that a man subject to the gout, is a life capable of being, insured, if he has no sickness at the time to make it an unequal contract. 2 Park, Ins. 583.

Mentioned in ?
References in periodicals archive ?
The coincidence of gouty arthritis and other rheumatic diseases is rare.
Our patient who was on long duration of treatment for gouty arthritis presented to our clinic with nonspecific knee pain and an incidental radiological evaluation of left hand showed the involvement of carpal bones.
Gouty arthritis of the spine: clinical presentation and effective treatments.
A snapshot of the global therapeutic scenario for Gouty Arthritis (Gout).
Ilaris is specifically indicated for the 'symptomatic treatment of adult patients with frequent gouty arthritis attacks (at least 3 attacks in the previous 12 months) in whom non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine are contraindicated, are not tolerated, or do not provide an adequate response, and in whom repeated courses of corticosteroids are not appropriate'.
Detection of periarticular urate deposits with dual energy CT in patients with acute gouty arthritis.
The differential diagnosis included inflammatory arthritidies (such as rheumatoid arthritis or psoriatic arthritis), gouty arthritis, amyloidosis, pigmented villonodular synovitis, and xanthomatosis.
Although crystal-induced arthritis is still a consideration, gout in the hip is usually a very rare and late manifestation of longstanding gouty arthritis.
Acute gouty arthritis without urate crystals identified on initial examination of synovial fluid: report on nine patients.
Global Markets Direct's, 'Gouty Arthritis (Gout) - Pipeline Review, H1 2012', provides an overview of the Gouty Arthritis (Gout) therapeutic pipeline.
The EC cleared llaris for treating adults suffering from gouty arthritis (gout) - a serious, chronic and progressive inflammatory disease.
Novartis AG stated that Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency gave its opinion in favor of the use of llaris in the treatment of patients with acute gouty arthritis who suffer frequent attacks, and whose symptoms should not be managed with treatment options.